Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Haferlach

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.
Leukemia|November 15, 2016
Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemiaC Baer, F Dicker, W Kern, et al.
Leukemia|September 7, 2007
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotypingC Haferlach, F Dicker, S Schnittger, et al.
Leukemia|February 9, 2007
Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patientsS Schnittger, U Bacher, C Haferlach, et al.
Leukemia|June 6, 2008
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotypeC Haferlach, F Dicker, H Herholz, et al.
British Journal of Cancer|December 6, 2006
Gene expression profiling for the diagnosis of acute leukaemiaT Haferlach, A Kohlmann, U Bacher, et al.
Leukemia|May 4, 2011
Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemiaS Schnittger, U Bacher, W Kern, et al.
Leukemia|June 11, 2016
Subtype-specific patterns of molecular mutations in acute myeloid leukemiaD Rose, T Haferlach, S Schnittger, et al.
Leukemia|September 30, 2016
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 casesA Stengel, W Kern, T Haferlach, et al.
Leukemia|October 10, 2015
Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysisV Mühlbacher, T Haferlach, W Kern, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Leukemia|March 23, 2007
The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factorsM Weisser, C Haferlach, W Hiddemann, et al.
Leukemia|November 15, 2016
Genetic characterization of MYD88-mutated lymphoplasmacytic lymphoma in comparison with MYD88-mutated chronic lymphocytic leukemiaC Baer, F Dicker, W Kern, et al.
Leukemia|September 7, 2007
Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotypingC Haferlach, F Dicker, S Schnittger, et al.
Leukemia|February 9, 2007
Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patientsS Schnittger, U Bacher, C Haferlach, et al.
Leukemia|June 6, 2008
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotypeC Haferlach, F Dicker, H Herholz, et al.
British Journal of Cancer|December 6, 2006
Gene expression profiling for the diagnosis of acute leukaemiaT Haferlach, A Kohlmann, U Bacher, et al.
Leukemia|May 4, 2011
Prognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemiaS Schnittger, U Bacher, W Kern, et al.
Leukemia|June 11, 2016
Subtype-specific patterns of molecular mutations in acute myeloid leukemiaD Rose, T Haferlach, S Schnittger, et al.
Leukemia|September 30, 2016
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 casesA Stengel, W Kern, T Haferlach, et al.
Leukemia|October 10, 2015
Array-based comparative genomic hybridization detects copy number variations with prognostic relevance in 80% of ALL with normal karyotype or failed chromosome analysisV Mühlbacher, T Haferlach, W Kern, et al.
Pageof 5